Laticort

Hydrocortisone butyrate, the active ingredient in Laticort, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various dermatologic conditions such as eczema, atopic dermatitis and psoriasis.

GNH USA supplies Laticort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydrocortisone butyrate is a topical corticosteroid indicated for inflammatory skin disorders. - Eczema: reduces redness, itching and swelling. - Atopic dermatitis: controls flare‑ups and improves skin barrier function. - Psoriasis: diminishes plaque formation and scaling. - Other inflammatory skin disorders: provides symptomatic relief by suppressing local immune response.

Adverse reactions are generally limited to the application site, but systemic absorption can occur with extensive use.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus or mild itching. - Dryness or flaking of the skin. - Erythema or mild redness. - Folliculitis or small pustules.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia (visible small blood vessels). - Secondary bacterial, fungal or viral infection. - Hypersensitivity reactions such as contact dermatitis. - Systemic effects like adrenal suppression with prolonged extensive use.

When using Laticort, consider the following safety measures. - Application area: limit to affected skin and avoid large surface areas. - Duration of use: restrict continuous use to the shortest period necessary. - Occlusive dressings: avoid unless directed by a healthcare professional. - Pre‑existing infections: do not apply on infected or ulcerated skin without medical advice. - Pediatric use: use with caution in children, following prescriber guidance. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Hydrocortisone butyrate may interact with other topical or systemic agents.

Major Interactions (Avoid): - Concurrent use with potent systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Application over skin treated with topical calcineurin inhibitors: may reduce efficacy of the latter.

Moderate Interactions (Monitor Closely): - Use with other skin‑irritating products (e.g., retinoids, benzoyl peroxide): may exacerbate local irritation. - Interaction with antiviral or antifungal creams: monitor for reduced therapeutic response. - Systemic immunosuppressants: observe for heightened infection risk.